Clinical trials
Phase 2 Idiopathic Pulmonary Fibrosis trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 3 |
| AstraZeneca | 1 |
| Beijing Kawin Technology Share-Holding Co., Ltd. | 1 |
| Bristol-Myers Squibb | 1 |
| Dragonboat Biopharmaceutical Company Limited | 1 |
| First Affiliated Hospital of Wenzhou Medical University | 1 |
| Guangdong Hengrui Pharmaceutical Co., Ltd | 1 |
| Haisco Pharmaceutical Group Co., Ltd. | 1 |
| InSilico Medicine Hong Kong Limited | 1 |
| Pliant Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Idiopathic Pulmonary Fibrosis | 18 |
| Lung Diseases, Interstitial | 3 |
| Pulmonary Fibrosis | 3 |
| Fibrosis | 1 |
| Idiopathic Interstitial Pneumonias | 1 |
| Lung Diseases | 1 |
| Pathologic Processes | 1 |
| Respiratory Tract Diseases | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.